FDA OKs New Therapy for Some Hemophilia Patients - NBC10 Boston
National & International News
The day’s top national and international news

FDA OKs New Therapy for Some Hemophilia Patients

Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that

Find NBC Boston in your area

Channel 10 on most providers

Channel 15, 60 and 8 Over the Air

    processing...

    NEWSLETTERS

    FDA OKs New Therapy for Some Hemophilia Patients
    AP/Genentech, Inc.
    This photo provided by Genentech, Inc. shows a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the Food and Drug Administration approved Hemlibra, the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    The Food and Drug Administration on Thursday approved Hemlibra (hem-LEE'-bruh), a weekly injection for hemophilia A patients who have developed resistance to standard medicines.

    Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that.

    Genentech, a subsidiary of Swiss drugmaker Roche, says that's half the cost of the only other option for patients with this resistance. That treatment requires an IV drip several times a week.

    Bikers Gather for National Cathedral's 'Blessing of the Bikes'

    [NATL-DC] Bikers Gather for National Cathedral's 'Blessing of the Bikes'

    Over 100 bikers gathered at the National Cathedral for the fourth annual Blessing of the Bikes, a Memorial Day weekend tradition that honors soldiers who didn't make it home.

    (Published Sunday, May 27, 2018)

    Hemophilia mostly affects males.